# Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria

> **NCT00561171** · PHASE2 · COMPLETED · sponsor: **Speedel Pharma Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Hypertension
- Type II Diabetes Mellitus

## Interventions

- **DRUG:** SPP635

## Key facts

- **NCT ID:** NCT00561171
- **Lead sponsor:** Speedel Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00561171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00561171, "Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00561171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*